Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin R Zamecnik

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|December 22, 2017
Bright Surface-Enhanced Raman Scattering with Fluorescence Quenching from Silica Encapsulated J-Aggregate Coated Gold NanoparticlesChristopher M Walters, Caroline Pao, Brandon P Gagnon, et al.
ACS Nano|November 11, 2017
Injectable Polymeric Cytokine-Binding Nanowires Are Effective Tissue-Specific ImmunomodulatorsColin R Zamecnik, Margaret M Lowe, David M Patterson, et al.
Molecular Pharmaceutics|February 5, 2021
Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor ImmunityElizabeth S Levy, Ryan Chang, Colin R Zamecnik, et al.
Biomaterials|November 23, 2019
An Injectable Cytokine Trap for Local Treatment of Autoimmune DiseaseColin R Zamecnik, Elizabeth S Levy, Margaret M Lowe, et al.
Journal of Cell Science|November 18, 2024
Apical integrins as a switchable target to regulate the epithelial barrierRaven J Peterson, Ryan C Reed, Colin R Zamecnik, et al.
Multiple Sclerosis and Related Disorders|January 6, 2023
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulatorsJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunityJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
JAMA Neurology|October 25, 2021
Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric SymptomsChristopher M Bartley, Claire Johns, Thomas T Ngo, et al.
JCI Insight|November 7, 2023
Validation of a murine proteome-wide phage display library for identification of autoantibody specificitiesElze Rackaityte, Irina Proekt, Haleigh S Miller, et al.
JCI Insight|January 14, 2022
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and functionJoseph J Sabatino, Kristen Mittl, William M Rowles, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Advanced Materials (Deerfield Beach, Fla.)|December 22, 2017
Bright Surface-Enhanced Raman Scattering with Fluorescence Quenching from Silica Encapsulated J-Aggregate Coated Gold NanoparticlesChristopher M Walters, Caroline Pao, Brandon P Gagnon, et al.
ACS Nano|November 11, 2017
Injectable Polymeric Cytokine-Binding Nanowires Are Effective Tissue-Specific ImmunomodulatorsColin R Zamecnik, Margaret M Lowe, David M Patterson, et al.
Molecular Pharmaceutics|February 5, 2021
Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor ImmunityElizabeth S Levy, Ryan Chang, Colin R Zamecnik, et al.
Biomaterials|November 23, 2019
An Injectable Cytokine Trap for Local Treatment of Autoimmune DiseaseColin R Zamecnik, Elizabeth S Levy, Margaret M Lowe, et al.
Journal of Cell Science|November 18, 2024
Apical integrins as a switchable target to regulate the epithelial barrierRaven J Peterson, Ryan C Reed, Colin R Zamecnik, et al.
Multiple Sclerosis and Related Disorders|January 6, 2023
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulatorsJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
Medrxiv : the Preprint Server for Health Sciences|September 28, 2021
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunityJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
JAMA Neurology|October 25, 2021
Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric SymptomsChristopher M Bartley, Claire Johns, Thomas T Ngo, et al.
JCI Insight|November 7, 2023
Validation of a murine proteome-wide phage display library for identification of autoantibody specificitiesElze Rackaityte, Irina Proekt, Haleigh S Miller, et al.
JCI Insight|January 14, 2022
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and functionJoseph J Sabatino, Kristen Mittl, William M Rowles, et al.
Pageof 3